We report a case of prophylactic management with methylene blue (MB) in an almost 4-year-old male with congenital methemoglobinemia type II. He has a CYB5R3 compound heterozygote mutation, causing a cytochrome-b(5) reductase deficiency. Since the MB treatment regimen has commenced, his methemoglobin level has been significantly lower. He has shown modest behavioral improvements (as assessed on the Achenbach behavior report scales). There have been no iatrogenic side effects. These findings are encouraging for symptomatic improvement with regular prophylactic MB treatment but represent a single case report, which must be interpreted with caution.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/pbc.25791 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dyskinetic Movement Disorder in Congenital Methemoglobinemia Type II.
Mov Disord Clin Pract
November 2024
Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Management of Congenital Methemoglobinemia in the Perioperative Setting: A Case Report and Review of Current Literature.
J Blood Med
August 2024
Department of Anesthesiology, Critical Care and Perioperative MedicineHamad Medical Corporation, Doha, Qatar.
Article Synopsis
- - Methemoglobinemia is a condition where hemoglobin is oxidized, preventing it from binding oxygen, leading to symptoms like cyanosis and potential heart failure; it can be congenital or acquired, with the congenital form being rare.
- - A case study of a 22-year-old man with congenital methemoglobinemia demonstrated the need for careful perioperative management during dental surgery, including avoiding certain anesthetics and ensuring appropriate oxygenation levels.
- - Effective management of congenital methemoglobinemia during surgery requires preoperative assessment, multidisciplinary care, avoidance of oxidizing agents, and strategies to maintain the patient's oxygenation and cardiovascular stability.
A novel stoploss mutation CYB5R3 c.906A>G(p.*302Trpext*42) involved in the pathogenesis of hereditary methemoglobinemia.
Clin Chim Acta
January 2025
Department of Traditional Chinese Medicine, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou 350001, China; Department of Hematology, Fujian Provincial Hospital, Fuzhou 350001, China. Electronic address:
Recessive congenital methemoglobinemia (RCM) is a hereditary autosomal disorder with an extremely low incidence rate. Here, we report a case of methemoglobinemia type I in a patient with congenital persistent cyanosis. The condition was attributed to a novel compound heterozygous mutation in CYB5R3, characterized by elevated methemoglobin levels (13.
View Article and Find Full Text PDFUnmasking Congenital Methemoglobinemia: A Novel Mutation Discovered in an Adult with Symptomatic Polycythemia.
Turk J Haematol
December 2024
All India Institute of Medical Sciences, Department of Hematology, New Delhi, India
Novel Compound Heterogeneous Mutations in CYB5R3 Gene Leading to Methemoglobinemia (Type I) in a Chinese Boy: Case Report and Relevant Comprehensive Analysis.
Acta Haematol
May 2024
Department of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, China.
Article Synopsis
- - Recessive congenital methemoglobinemia (RCM) is a genetic disorder caused by mutations in the CYB5R3 gene, resulting in a deficiency of the NADH cytochrome b5 reductase enzyme; it can be classified into two types based on the extent of red blood cell impact.
- - A case study of a 5-year-old boy with cyanosis and low oxygen saturation revealed two specific mutations in the CYB5R3 gene that led to abnormal protein structures, contributing to his condition of RCM type I.
- - The findings indicate that the severity of methemoglobinemia, whether classified as type I or II, correlates with the nature of CYB5R3
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!